0001062993-25-007763.txt : 20250422 0001062993-25-007763.hdr.sgml : 20250422 20250422143902 ACCESSION NUMBER: 0001062993-25-007763 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250422 DATE AS OF CHANGE: 20250422 EFFECTIVENESS DATE: 20250422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NurExone Biologic Inc. CENTRAL INDEX KEY: 0001995074 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-544231 FILM NUMBER: 25857170 BUSINESS ADDRESS: STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA STATE: L3 ZIP: 3200003 BUSINESS PHONE: 972 52-4803034 MAIL ADDRESS: STREET 1: MINUS 1 ENTRY, GROUND FLOOR OF BLDG B STREET 2: GUTWIRTH INDUSTRIAL PARK CITY: TECHNION CITY, HAIFA STATE: L3 ZIP: 3200003 D 1 primary_doc.xml X0708 D LIVE 0001995074 NurExone Biologic Inc. MINUS 1 ENTRY, GROUND FLOOR OF BLDG B GUTWIRTH INDUSTRIAL PARK TECHNION CITY, HAIFA L3 ISRAEL 3200003 972 52-4803034 ALBERTA, CANADA WALMER CAPITAL CORP. ENERSPAR CORP. None Corporation true Lior Shaltiel Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Director Eran Ovadya Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Yoram Drucker Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Executive Officer Oded Orgil Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director James Richardson Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Gadi Riesenfeld Minus 1 entry, ground floor of Building Gutwirth Industrial Park Technion City, Haifa L3 ISRAEL 3200003 Director Biotechnology Decline to Disclose 06b false 2025-04-09 false true true true true Units consisting of 1 cm sh and 1 cm sh wrt. Each wrt shall be exercisable to acquire 1 cm sh at a price of C$0.85 per wrt for a period of 36 months following the closing date. false 0 3756009 1627604 2128405 Total Offering Amount price of units (3,543,238xC$0.65) plus exercise price of the shares underlying the wrts (3,543,238xC$0.85) sold in this offering. No guarantee the wrts will be exercised. Exchange rate of CAD$1.00=USD$0.7067. false 1 0 0 0 false NurExone Biologic Inc. /s/ Eran Ovadya Eran Ovadya Chief Financial Officer 2025-04-22